The Rising FDA Approvals is Expected to Drive the Global Contrast Media/Contrast Agent Market

Published: Dec 2021

The global contrast media/contrast agent market is anticipated to grow at a CAGR of around 5% during the forecast period (2021-2027). The rising FDA approvals are expected to drive the market during the forecast period. Several market players are actively participating in the R&D of contrast agents to get FDA approvals.

For instance, Bracco Imaging SpA had received FDA approval in December 2020 for ProHance, an MRI contrast agent which now can be used in neonates and pediatric patients under two years of age. Similarly, Bayer AG had received FDA approval in July 2019 for Gadavist, a gadolinium-based contrast agent which is used for the diagnosis of coronary artery diseases through cardiac MRI.

Browse the full report description of "Global Contrast Media/Contrast Agent Market Size, Share & Trends Analysis Report by Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, and Barium-based Contrast Media), by Procedure (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound), and by Indication (Cardiovascular Disorders, Oncology, Gastrointestinal Disorders, Neurological Disorders, and Others) Forecast Period 2021-2027" at https://www.omrglobal.com/industry-reports/contrast-media-Contrast-agent-market

Market Coverage

The market number available for – 2020-2027

Base year- 2020

Forecast period- 2021-2027

Segment Covered- 

o By Type

o By Procedure

o By Indication

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape-Bayer AG, Bracco Imaging SPA, GE Healthcare, Lantheus Medical Imaging, Inc.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How has COVID-19 impacted the market?

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global Contrast Media/Contrast Agent Market Report Segment

By Type

  •      Iodinated Contrast Media
  •      Gadolinium-based Contrast Media
  •      Microbubble Contrast Media
  •     Barium-based Contrast Media

By Procedure

  •     X-ray/Computed Tomography (CT)
  •     Magnetic Resonance Imaging (MRI)
  •       Ultrasound

By Indication

  •     Cardiovascular Disorders
  •     Oncology
  •     Gastrointestinal Disorders
  •     Neurological Disorders
  •     Other Indications

Global Contrast Media/Contrast Agent Market Report Segment by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/contrast-media-Contrast-agent-market